Loading…
← CockpitCompetitor Analysis › EXE.TO Extendicare Inc.Open in the cockpit ↗

Extendicare Inc.EXE.TOCompetitor analysis, valuation and peers

Canada · CAD·Health Care›Hospital/Nursing Management

Canadian operator of long-term care and retirement homes, also providing home healthcare services.

≈ A long-term care/nursing home operator like a smaller Genesis HealthcareMomentum weak 35
Mkt cap
$1.87B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$10.8M
20-day average traded
Fwd P/E
19.4×
forward earnings
ROIC−WACC
+5.2 pp
WACC 8.2%
Hurdle
+3 pp
Req g minus delivered
Next earnings
118 days
4 Mar 2027
Close · CADC$27.61
1D+1.2%
1W+3.9%
1M-0.7%
3M-14.9%
6M-8.6%
YTD+29.3%
1Y+67.6%
ATR %3.9%
52w lowhigh29.5% off high

What Extendicare does

Canadian operator of long-term care and retirement homes, also providing home healthcare services.

Is paid mostly by provincial governments, which fund care for each resident, with residents covering accommodation within regulated limits, so income depends on provincial funding rules and bed occupancy. ParaMed, its home-care unit, is paid under government-funded contracts for nursing and support hours.

In one line: A long-term care/nursing home operator like a smaller Genesis Healthcare.

Products and services

  • Long-term care homes
  • Retirement living
  • Home healthcare services

Customers

  • Elderly residents/patients
  • Provincial healthcare funders

Where it sits in the supply chain

  • Healthcare services
  • Long-term care/nursing home operations
  • Home healthcare services

What could go right

  • Ageing population demand for care beds
  • Government funding increases for long-term care

What could go wrong

  • Staffing cost/shortage pressures
  • Regulatory/funding policy risk

Moat: narrow (regulatory licence, installed base). Licensed long-term care beds and provincial funding relationships are regulated and slow to expand, limiting new supply.

Headquarters: Markham, Canada · Founded: 1968 · Employees: 28,000

Named competitors

Extendicare at a glance

Size Extendicare (EXE.TO) is a Canada Health Care company (Hospital/Nursing Management) with a market value of $1.87B, the 192nd largest of 420 Canada companies the cockpit tracks. Shares closed at C$27.61 on 6 Nov 2026.

Performance Over six months the shares fell 8.6%, against +2.2% for the median peer and +5.2% for the Canada market (cap-weighted) — 8th lowest of 21 in its peer set.

Growth Revenue grew 31.1% over the last twelve months (peer median +6.2%); the operating margin is 8.8% (peer median 10.3%).

Valuation It trades at 19.4× forward earnings against a peer median of 38.1× (3rd cheapest of 18).

Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 5.2 points above its cost of capital (8.2% WACC).

Next results Next results expected around 4 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 101EXE.TO 83
Six months, rebased to 100: Extendicare against the median of its 20 peers (local-currency closes).

Extendicare financials

Reported figures in CAD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueC$1.98BC$1.66BC$1.47BC$1.30BC$1.22B
Revenue growth—+13%+12%+7%—
Gross profitC$240MC$200MC$168MC$118MC$76.8M
EBITDAC$221MC$176MC$145MC$95.2MC$57.5M
Net incomeC$121MC$96.7MC$75.2MC$34.0M-C$4.68M
Free cash flowC$54.0MC$63.4MC$101M-C$105M-C$3.30M
Capital expenditureC$90.4MC$102MC$42.0MC$129MC$102M
Total debtC$646MC$330MC$292MC$335MC$384M

Quarterly statements and history in the cockpit →

Extendicare competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%0%+20%+40%+60%301267BKDSIA000516AEVS301293ARDT600763SPIRAINBOWCVSGSGRYPARKHOSPSGDSRHKNHCYATHARTHJLHLEXE.TO6-month return →1-month return →
Up and to the right = strong over both horizons. Extendicare is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%50×100×150×301267BKDSIAAEVS301293ARDTSPIRAINBOWBSLSGRYPARKHOSPSKIMSYATHARTHJLHLEXE.TORevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Extendicare is the large dot.

Capital: growth delivered against growth the price implies

0%+10%+20%+30%0%10%20%30%301267BKDSIA000516AEVSARDT600763SPIRAINBOWBSLCVSGSGRYPARKHOSPSGDSNHCEXE.TOGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Extendicare is the large dot.

Extendicare competitors and peer comparison

Head to head with its named competitors (EXE.TO vs SIA.TO vs CSH-UN.TO)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Extendicare EXE.TO$1.87B-9%+31%9%19.4×11.2%
Sienna Senior Living SIA.TO$1.63B-11%+16%10%38.1×19.6%
Chartwell Retirement Residences CSH-UN.TO$5.25B+3%+24%13%147.6×n/a

How Extendicare compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Extendicare against its 20 peers (data as of 6 Nov 2026)
MeasureEXE.TOPeer medianRank in peer set
1-month return-0.7%+2.4%7th lowest of 21
6-month return-8.6%+2.2%8th lowest of 21
Distance from 52-week high-29.5%-15.8%3rd lowest of 21
Revenue growth (TTM)+31.1%+6.2%2nd highest of 21
Operating margin8.8%10.3%10th lowest of 20
Forward P/E19.4×38.1×3rd cheapest of 18
Growth the price implies (Req g, 7 yrs)11.2%13.6%7th least demanding of 16
Growth delivered (Del g)+8.5%+9.7%6th lowest of 16
Hurdle (Req g minus delivered)+2.7 pp+1.6 pp8th most demanding of 16
ROIC minus cost of capital+5.2 pp-2.4 pp2nd highest of 20
EV / EBITDA14.3×13.6×7th most expensive of 14
Net debt / EBITDA2.5×4.3×7th least indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Extendicare EXE.TOCanada$1.87B-9%+31%9%19.4×11.2%+8.5%
Huaxia Eye Hospital 301267.SZChina$1.92B-16%+2%15%24.7×3.8%+10.4%
Brookdale Senior Living BKDUnited States$2.15B-31%-4%5%127.7×22.4%-1.4%
Sienna Senior Living SIA.TOCanada$1.63B-11%+16%10%38.1×19.6%+8.6%
Xi'an International Medical Investment 000516.SZChina$1.54B0%-1%-2%n/a13.6%+20.6%
Aevis Victoria AEVS.SWSwitzerland$1.49B+9%+15%-6%107.9×26.6%+10.2%
Sanbo Hospital Management 301293.SZChina$1.48B-21%+17%6%148.9×n/an/a
Ardent Health ARDTUnited States$2.44B+71%+3%4%14.5×4.0%+8.7%
Topchoice Medical 600763.SSChina$2.51B-11%+7%26%26.7×13.6%+6.9%
Spire Healthcare SPI.LUnited Kingdom$1.34B+68%+2%8%19.5×9.8%+11.4%
Rainbow Childrens Medicare RAINBOW.NSIndia$1.34B-4%+23%22%39.4×30.2%+21.2%
Raffles Medical BSL.SISingapore$1.25B-15%-3%11%27.3×-2.4%+6.1%
CVS CVSG.LUnited Kingdom$1.23B+20%+6%11%14.3×13.7%+6.9%
Surgery Partners SGRYUnited States$2.99B+61%+4%14%62.5×13.8%+12.2%
Park Medi World PARKHOSPS.NSIndia$1.15B+2%+21%n/a28.3×30.5%+10.2%
Ramsay Generale de Sante GDS.PAFrance$1.09B-15%+3%4%n/a6.3%+6.0%
Krishna Institute of Medical Sciences KIMS.NSIndia$3.21B+2%+31%12%70.0×n/an/a
Rhon-klinikum RHK.DEGermany$1.08B+14%+5%3%22.5×n/an/a
National HealthCare NHCUnited States$3.27B+11%+7%-8%n/a7.9%+9.7%
Yatharth Hospital and Trauma Care Services YATHARTH.NSIndia$1.05B+25%+50%16%41.0×n/an/a
Jupiter Life Line Hospitals JLHL.NSIndia$1,000M+14%+17%16%48.5×n/an/a

Questions

Who are Extendicare's main competitors?
Named competitors: Sienna Senior Living (SIA.TO), Chartwell Retirement Residences (CSH-UN.TO). The cockpit's measured peer set (industry) also includes Huaxia Eye Hospital (301267.SZ), Brookdale Senior Living (BKD), Sienna Senior Living (SIA.TO), Xi'an International Medical Investment (000516.SZ), Aevis Victoria (AEVS.SW), Sanbo Hospital Management (301293.SZ).
Is Extendicare expensive compared with its peers?
On forward p/e it trades at 19.4× against a peer median of 38.1×, 3rd cheapest of 18 in its peer set. For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Extendicare stock performed?
Over six months to 6 Nov 2026 the shares returned -8.6% against +2.2% for the median peer; over one year +67.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.